High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons
出版年份 2020 全文链接
标题
High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons
作者
关键词
-
出版物
Molecular Autism
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-11-19
DOI
10.1186/s13229-020-00387-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A Coordinated Attack: Rett Syndrome Therapeutic Development
- (2019) Rocco G. Gogliotti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer’s Disease
- (2019) Mar Cuadrado-Tejedor et al. Frontiers in Aging Neuroscience
- Human Cortical Organoids Expose a Differential Function of GSK3 on Cortical Neurogenesis
- (2019) Alejandro López-Tobón et al. Stem Cell Reports
- Dosage analysis of the 7q11.23 Williams region identifies BAZ1B as a major human gene patterning the modern human face and underlying self-domestication
- (2019) Matteo Zanella et al. Science Advances
- Phase I study of resminostat, an HDAC inhibitor, combined with S-1 in patients with pre-treated biliary tract or pancreatic cancer
- (2018) Masafumi Ikeda et al. INVESTIGATIONAL NEW DRUGS
- Repurposing available drugs for neurodevelopmental disorders: The fragile X experience
- (2018) Michael R. Tranfaglia et al. NEUROPHARMACOLOGY
- Histone deacetylase inhibitor MS-275 restores social and synaptic function in a Shank3-deficient mouse model of autism
- (2018) Kaijie Ma et al. NEUROPSYCHOPHARMACOLOGY
- Pathological histone acetylation in Parkinson’s disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition
- (2018) Ian F. Harrison et al. NEUROSCIENCE LETTERS
- The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
- (2018) Maria Cosenza et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase I study of domatinostat (4SC-202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies
- (2018) Bastian von Tresckow et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Entinostat: a promising treatment option for patients with advanced breast cancer
- (2017) Roisin M Connolly et al. Future Oncology
- Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study
- (2017) Vincent Ribrag et al. HAEMATOLOGICA
- CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial
- (2017) Yasuhiro Oki et al. HAEMATOLOGICA
- Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma
- (2017) Sonia Coni et al. Scientific Reports
- iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease
- (2017) Takayuki Kondo et al. Cell Reports
- Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study
- (2017) Vincent Ribrag et al. HAEMATOLOGICA
- CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial
- (2017) Yasuhiro Oki et al. HAEMATOLOGICA
- Panobinostat: A histone deacetylase inhibitor for the treatment of relapsed or refractory multiple myeloma
- (2016) K. Wahaib et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Haploinsufficiency of BAZ1B contributes to Williams syndrome through transcriptional dysregulation of neurodevelopmental pathways
- (2016) Matthew A. Lalli et al. HUMAN MOLECULAR GENETICS
- Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells
- (2016) Seok-Man Ho et al. METHODS
- A human neurodevelopmental model for Williams syndrome
- (2016) Thanathom Chailangkarn et al. NATURE
- BET bromodomain inhibition promotes neurogenesis while inhibiting gliogenesis in neural progenitor cells
- (2016) Jingjun Li et al. Stem Cell Research
- Differentiation of control and ALS mutant human iPSCs into functional skeletal muscle cells, a tool for the study of neuromuscolar diseases
- (2016) Jessica Lenzi et al. Stem Cell Research
- Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells
- (2015) Anderly C. Chueh et al. ANTIOXIDANTS & REDOX SIGNALING
- FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
- (2015) H.-Z. Lee et al. CLINICAL CANCER RESEARCH
- Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma
- (2015) Song Mu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Altered neuronal network and rescue in a human MECP2 duplication model
- (2015) S Nageshappa et al. MOLECULAR PSYCHIATRY
- Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams–Beuren Syndrome
- (2015) Cristina Borralleras et al. MOLECULAR THERAPY
- Epigenetic therapy for Friedreich ataxia
- (2014) Elisabetta Soragni et al. ANNALS OF NEUROLOGY
- Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population
- (2014) Bernard J Crespi et al. BMC NEUROSCIENCE
- Phase I First-in-Human Study of CUDC-101, a Multitargeted Inhibitor of HDACs, EGFR, and HER2 in Patients with Advanced Solid Tumors
- (2014) T. Shimizu et al. CLINICAL CANCER RESEARCH
- 7q11.23 dosage-dependent dysregulation in human pluripotent stem cells affects transcriptional programs in disease-relevant lineages
- (2014) Antonio Adamo et al. NATURE GENETICS
- The role of de novo mutations in the genetics of autism spectrum disorders
- (2014) Michael Ronemus et al. NATURE REVIEWS GENETICS
- Histone deacetylase inhibitors
- (2013) Marije Slingerland et al. ANTI-CANCER DRUGS
- A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors
- (2013) B. Venugopal et al. CLINICAL CANCER RESEARCH
- Autism
- (2013) Meng-Chuan Lai et al. LANCET
- HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
- (2013) Claudia Simões-Pires et al. Molecular Neurodegeneration
- Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells
- (2013) Yingsha Zhang et al. NEURON
- HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain
- (2013) Franziska Denk et al. PAIN
- Duplication of GTF2I Results in Separation Anxiety in Mice and Humans
- (2012) Carolyn B. Mervis et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Growth Defects and Impaired Cognitive–Behavioral Abilities in Mice with Knockout for Eif4h, a Gene Located in the Mouse Homolog of the Williams-Beuren Syndrome Critical Region
- (2012) Simona Capossela et al. AMERICAN JOURNAL OF PATHOLOGY
- Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression
- (2012) Gabsang Lee et al. NATURE BIOTECHNOLOGY
- Class I histone deacetylase inhibition ameliorates social cognition and cell adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder
- (2012) Andrew G. Foley et al. NEUROPHARMACOLOGY
- Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours
- (2011) A R A Razak et al. BRITISH JOURNAL OF CANCER
- Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor
- (2011) Yanis Boumber et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Biochemistry and biology of the inducible multifunctional transcription factor TFII-I: 10years later
- (2011) Ananda L. Roy GENE
- Unknown
- (2011) Antonio Furlan et al. MOLECULAR MEDICINE
- Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism
- (2011) Stephan J. Sanders et al. NEURON
- Pharmacokinetic and pharmacodynamic properties of an oral formulation of the histone deacetylase inhibitor Belinostat (PXD101)
- (2010) N. L. Steele et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Copy number variants at Williams–Beuren syndrome 7q11.23 region
- (2010) Giuseppe Merla et al. HUMAN GENETICS
- Williams–Beuren Syndrome
- (2010) Barbara R. Pober NEW ENGLAND JOURNAL OF MEDICINE
- Two New Pimelic Diphenylamide HDAC Inhibitors Induce Sustained Frataxin Upregulation in Cells from Friedreich's Ataxia Patients and in a Mouse Model
- (2010) Myriam Rai et al. PLoS One
- Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
- (2009) Nahum Sonenberg et al. CELL
- Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
- (2009) D. Palmieri et al. CLINICAL CANCER RESEARCH
- Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome
- (2009) Nathalie Van der Aa et al. European Journal of Medical Genetics
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile
- (2009) A. Antonell et al. JOURNAL OF MEDICAL GENETICS
- HDAC2 negatively regulates memory formation and synaptic plasticity
- (2009) Ji-Song Guan et al. NATURE
- Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety
- (2009) Brigitta B. Gundersen et al. NEUROPHARMACOLOGY
- The genomic basis of the Williams – Beuren syndrome
- (2008) C. Schubert CELLULAR AND MOLECULAR LIFE SCIENCES
- Phase I Pharmacokinetic and Pharmacodynamic Study of LAQ824, a Hydroxamate Histone Deacetylase Inhibitor with a Heat Shock Protein-90 Inhibitory Profile, in Patients with Advanced Solid Tumors
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice
- (2008) E. A. Thomas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice
- (2007) E. J. Young et al. GENES BRAIN AND BEHAVIOR
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started